Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Don't waste time with individual license agreements for TFC1

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Jun 17, 2023 3:50pm

117 Views

Post# 35501964

RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1

The company certainly need some help in communication. I think you made an important observation that I would translate that the NR is very scientific oriented and not business oriented. If they say that a scientific break-through has been achieved that will revolutionate the industry in terms of forever young people might notice the company. Currently, the message does not go through.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario